Follow us on :

    Submit RFI

Meet Our Team

A Place For Crafting And Bringing Ideas

Leadership Team

Dr. Shawki Salem, Ph.D


Dr. Shawki Salem, Ph.D. in Biostatistics, founded Symbiance in 1992, after spending seventeen years in the pharmaceutical industry as a Statistician, Senior Statistician, Director and Senior Director of Biostatistics

Ilango Ramanujam

President & Chief Executive Officer

Ilango, A Passionate Life Sciences Entrepreneur. Has over three decades of experience in Pharmaceutical, Bio-tech and CRO industry. Conceptualized and designed products to manage clinical data from collection to submission. Created and Built – Development and Services Teams – globally which delivered several regulatory critical systems in Clinical Data Sciences, with uncompromised quality to Pharmaceutical companies.

Dr. Chao Chen

Senior Director, Biostatistics

Chao has hands-on experience in statistical methodology as well as in-depth understanding of the underlying theory. His therapeutic experience covers a wide spectrum with significant contribution in neurology, oncology, cardiology and ophthalmology. Serving as an unblinded biostatistician and working closely with clinicians to review interim data under data monitoring committee set-up is another area Chao has dedicated to. In addition to coordinating all the biostatistical activities in clinical trials, he also published research articles in biostatistical and clinical journals.

Eric Weising

Director, Data Management

Eric, With over 20 years of experience at Symbiance, is the Director of our Clinical Data Management Unit. By combining his critical thinking and problem-solving skills with his degree in Mathematics from Kean University, Eric has accumulated experience in Phases I-IV (with particular expertise in Phases II and III) and has substantial experience in such therapeutic areas as oncology, pain management, Alzeheimer’s disease, depression/anxiety, epilepsy and hypertension. Eric’s responsibilities have run the gamut from performing quality assurance of outputs (TLF) and SAS programming to clinical data management and biostatistical analysis.

Alphons Philips PhD, MBA

Vice President, Pharmacovigilance and Regulatory Operations

Alphons is an accomplished life Sciences Expert with over 20 years of experience in building drug safety practices and life sciences technology services globally. His experiences includes successful establishment of Pharmacovigilance systems in Europe, US and in India. He worked with global major pharma/biotech companies like Wyeth, Pfizer, Johnson & Johnson and, other global CROs. The industries he worked include Biopharmaceuticals, Radiopharmaceuticals, Cosmeceuticals, Medical devices and consumer products. Being a industry expert in the area of Aggregate reports, signal detection and global risk management plans, he worked with global companies building life sciences technologies for safety, clinical and regulatory.

Senthilkumar Karuppiah

Director, Statistical Programming

Managing Statistical Programming Team with significant understanding of the drug development process, and strong experience in regulatory submission and the key Statistical Reporting automation process, with a well-established track record of organisational structure, in order to, Lead and oversee all the aspects of Statistical Programming disciplines.

Caryl Parker

Director of Human Resources

Caryl joined Symbiance in 2002 as an Office Administrator and quickly moved up the ranks to the position of Office Manager and has since held a wide range of roles. Prior to her appointment as Director of Human Resources, Caryl was the Manager – HR & Contracts. Caryl holds a BA in Business Economics. In her free time, she enjoys reading, the theater and traveling.

Here at Symbiance, she helps to shape and integrate our approach to recruiting and talent development, performance management, and workplace culture in alignment with the organization’s strategic plan at a period of significant growth and change. She has a deep sense of commitment to advancing diversity and inclusion and is a diligent professional always willing to take the initiative when the company needs it most.

She has the experience to lead through change related to acquisitions and partnerships to maintain and strengthen culture and workforce which will be vital for our growth in the near future.

She is a strategic thinker who values intellectual curiosity and takes a solutions-based approach to ensure Symbiance is an employer of choice, cultivating our culture as a learning organization, and accelerating our efforts to be a more diverse and inclusive organization.